Xie Zhibo, Zhu Zhen, Xu Jin, Mao Naiying, Cui Aili, Wang Wenhui, Wang Yage, Zhang Zhibo, Xia Baicheng, Wang Haoran, Sun Zhen, Zhang Yan
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Medical Virology and Viral Disease, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Henan Provincial Center for Disease Control and Prevention, Luohe City, Henan Province, China.
China CDC Wkly. 2024 May 17;6(20):450-456. doi: 10.46234/ccdcw2024.087.
This study examines the seasonal and genetic characteristics of human metapneumovirus (HMPV) in Henan from 2017 to 2023.
Samples from patients with acute respiratory infection (ARI) testing positive for HMPV were subjected to real-time reverse transcription polymerase chain reaction The G gene was amplified and sequenced from these samples for epidemiological and phylogenetic analysis.
We enrolled 2,707 ARI patients from October 2017 to March 2023, finding an HMPV positivity rate of 6.17% (167/2,707). Children under five exhibited the highest infection rate at 7.78% (138/1,774). The 2018 and 2019 HMPV outbreaks predominantly occurred in spring (March to May), with peak positivity rates of 31.11% in May 2018 and 19.57% in May 2019. A notable increase occurred in November 2020, when positivity reached a historic high of 42.11%, continuing until January 2021. From February 2021 through March 2023, no significant seasonal peaks were observed, with rates ranging from 0% to 8.70%. Out of 81 G gene sequences analyzed, 46.91% (38/81) were identified as subtype A (A2c: 45.67%, 37/81; A2b: 1.23%, 1/81) and 53.09% (43/81) as subtype B (B1: 9.88%, 8/81; B2: 43.21%, 35/81). Notably, an AAABBA switch pattern was observed in HMPV subtypes. The dominant strains were A2c in subtype A and B2 in subtype B.
Six years of surveillance in Henan Province has detailed the seasonal and genetic dynamics of HMPV, contributing valuable insights for the control and prevention of HMPV infections in China. These findings support the development of targeted HMPV vaccines and immunization strategies.
本研究调查了2017年至2023年河南省人偏肺病毒(HMPV)的季节性和基因特征。
对急性呼吸道感染(ARI)患者中检测出HMPV呈阳性的样本进行实时逆转录聚合酶链反应。从这些样本中扩增G基因并测序,进行流行病学和系统发育分析。
我们纳入了2017年10月至2023年3月期间的2707例ARI患者,发现HMPV阳性率为6.17%(167/2707)。五岁以下儿童的感染率最高,为7.78%(138/1774)。2018年和2019年HMPV疫情主要发生在春季(3月至5月),2018年5月阳性率峰值为31.11%,2019年5月为19.57%。2020年11月出现显著上升,阳性率达到历史最高的42.11%,持续到2021年1月。从2021年2月到2023年3月,未观察到明显的季节性高峰,阳性率在0%至8.70%之间。在分析的81个G基因序列中,46.91%(38/81)被鉴定为A亚型(A2c:45.67%,37/81;A2b:1.23%,1/81),53.09%(43/81)为B亚型(B1:9.88%,8/81;B2:43.21%,35/81)。值得注意的是,在HMPV亚型中观察到AAABBA转换模式。A亚型中的优势毒株是A2c,B亚型中的优势毒株是B2。
河南省六年的监测详细阐述了HMPV的季节性和基因动态,为中国控制和预防HMPV感染提供了有价值的见解。这些发现支持开发针对性的HMPV疫苗和免疫策略。